← Product Code [DXN](/submissions/CV/subpart-b%E2%80%94cardiovascular-diagnostic-devices/DXN) · K021756 # WELCH ALLYN ABPM 6100 (K021756) _Welch Allyn, Inc. · DXN · Jun 27, 2002 · Cardiovascular · SESE_ **Canonical URL:** https://fda.innolitics.com/submissions/CV/subpart-b%E2%80%94cardiovascular-diagnostic-devices/DXN/K021756 ## Device Facts - **Applicant:** Welch Allyn, Inc. - **Product Code:** [DXN](/submissions/CV/subpart-b%E2%80%94cardiovascular-diagnostic-devices/DXN.md) - **Decision Date:** Jun 27, 2002 - **Decision:** SESE - **Submission Type:** Special - **Regulation:** 21 CFR 870.1130 - **Device Class:** Class 2 - **Review Panel:** Cardiovascular - **Attributes:** Pediatric ## Indications for Use The Welch Allyn ABPM 6100 is a non-invasive oscillometric ambulatory blood pressure monitor that is to be used with ABPM 6100 Software, a PC based computer program. The ABPM 6100 is capable of recording and displaying up to 250 measurements of systolic and diastolic blood pressure and heart rate. It is intended for use as an aid or adjunct to diagnosis and treatment when it is necessary to measure adult or pediatric patients systolic and diastolic blood pressures over an extended period of time. The system is only for measurement, recording, and display. It makes no diagnosis. ## Device Story Microprocessor-based ambulatory blood pressure monitor; uses oscillometric step deflation technique. Internal electric pump inflates cuff; two valves control deflation. Analyzes arterial blood pressure pulses during deflation to determine systolic/diastolic blood pressure and heart rate. Stores up to 250 measurements. Used in clinical settings or by patients for ambulatory monitoring; operated by physician or patient. Results downloaded to PC software for analysis. Device displays readings on LCD; display can be disabled for patient privacy. Provides data for clinical decision-making; does not perform automated diagnosis. ## Clinical Evidence Bench testing only. Compliance with recognized standards EN60601-1, EN60601-1-1, EN60601-1-2, EN60601-2-30, and AAMI SP10 confirmed. ## Technological Characteristics Microprocessor-based oscillometric monitor; internal electric pump and dual-valve deflation system. Dimensions/form factor: ambulatory wearable. Connectivity: PC-based software for data download. Standards: EN60601-1, EN60601-1-1, EN60601-1-2, EN60601-2-30, AAMI SP10. ## Regulatory Identification A noninvasive blood pressure measurement system is a device that provides a signal from which systolic, diastolic, mean, or any combination of the three pressures can be derived through the use of tranducers placed on the surface of the body. ## Predicate Devices - Pressure Trak System Model 222-B ([K010622](/device/K010622.md)) - Welch Allyn Ambulatory Blood Pressure Monitor ([K925899](/device/K925899.md)) ## Submission Summary (Full Text) > This content was OCRed from public FDA records by [Innolitics](https://innolitics.com). If you use, quote, summarize, crawl, or train on this content, cite Innolitics at https://innolitics.com. > > Innolitics is a medical-device software consultancy. We help companies design, build, and clear FDA-regulated software and AI/ML devices, including [a 510(k)](https://innolitics.com/services/510ks/), [a De Novo](https://innolitics.com/services/regulatory/), [a SaMD](https://innolitics.com/services/end-to-end-samd/), [an AI/ML medical device](https://innolitics.com/services/medical-imaging-ai-development/), or [an FDA regulatory strategy](https://innolitics.com/services/regulatory/). {0}------------------------------------------------ K021756 page 1 of 2 # JUN 2 7 2002 # V. 510(k) Summary 188 [As described in CFR 807.92] | Submitted by: | Welch Allyn Inc.
4341 State Street Road
Skaneateles Falls, NY 13153 | |----------------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------| | Contact Person: | David Klementowski
Corporate Regulatory Affairs Manager | | Date Prepared: | 20 May 2002 | | Proprietary Name: | Welch Allyn ABPM 6100 | | Common Name: | Ambulatory Blood Pressure Monitor | | Classification Name: | Class II 870.1110 Blood Pressure Computer | | Predicate Devices: | Pressure Trak System Model 222-B
SunTech Medical Instruments
510(k) Document Control Number K010622

Welch Allyn Ambulatory Blood Pressure Monitor
Welch Allyn, Inc.
510(k) Document Control Number K925899 | 、 {1}------------------------------------------------ K021756 page 2 of 2 ## Description of the Device: The Welch Allyn ABPM 6100 is a microprocessor based ambulatory blood pressure monitor that uses an oscillometric step deflation technique to determine blood pressure. An internal electric pump is used to inflate the cuff and two valves control deflation. During cuff deflation, small cuff pressure changes (resulting from arterial blood pressure pulses) are analyzed by the microprocessor, in order to determine the blood pressure. The Welch Allyn ABPM 6100 has the ability to make blood pressure determinations at predetermined intervals (normally from a schedule determined by the physician), or on demand (by using the stop/start key). Each reading is stored in memory, allowing the physician to download all the results obtained during the study period after the study has concluded to be analyzed by PC software. The readings can be displayed on the LCD or the LCD can be disabled to prevent the patient from seeing the readings (see attachment I for photographs of the device). #### Intended Use The Welch Allyn ABPM 6100 is a non-invasive oscillometric ambulatory blood pressure monitor that is to be used with ABPM 6100 Software, a PC based computer program. The ABPM 6100 is capable of recording and displaying up to 250 measurements of systolic and diastolic blood pressure and heart rate. It is intended for use as an aid or adjunct to diagnosis and treatment when it is necessary to measure adult or pediatric patients systolic and diastolic blood pressures over an extended period of time. The system is only for measurement, recording, and display. It makes no diagnosis. ### Action Taken to Comply with Section 514 of the Act The agency has recognized the following standards: - a) EN60601-1 - b) EN60601-1-1 - c) EN60601-1-2 - d) EN60601-2-30 - e) AAMI SP10 The Welch Allyn ABPM 6100 meets the requirements called out in these standards. Evidence of compliance is on file at Welch Allyn and is available for review upon demand. {2}------------------------------------------------ Image /page/2/Picture/2 description: The image is a seal for the U.S. Department of Health & Human Services. The seal is circular and contains the department's logo, which is a stylized caduceus. The words "DEPARTMENT OF HEALTH & HUMAN SERVICES • USA" are arranged around the top of the circle. Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850 JUN 2 7 2002 Welch Allyn, Inc. c/o Mr. David Klementowski Corporate Regulatory Affairs Manager 4341 State Street Road Skaneateles Falls, NY 13153 Re: K021756 Trade Name: Welch Allyn ABPM 6100 Regulation Number: 21 CFR 870.1130 Regulation Name: Non-invasive Blood Pressure Measurement System Regulatory Class: Class II (two) Product Code: DXN Dated: June 18, 2002 Received: June 19, 2002 Dear Mr. Klementowski: We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register. {3}------------------------------------------------ Page 2 - Mr. David Klementowski Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050. This letter will allow you to begin marketing your device as described in your Section 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market. If you desire specific advice for your device on our labeling regulation (21 CFR Part 801 and additionally 21 CFR Part 809.10 for in vitro diagnostic devices), please contact the Office of Compliance at (301) 594-4646. Additionally, for questions on the promotion and advertising of your device, please contact the Office of Compliance at (301) 594-4639. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). Other general information on your responsibilities under the Act may be obtained from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 443-6597 or at its Internet address http://www.fda.gov/cdrh/dsma/dsmamain.html Sincerely yours, signature Donna-Bea Tillman, Ph.D. Acting Director Division of Cardiovascular and Respiratory Devices Office of Device Evaluation Center for Devices and Radiological Health Enclosure {4}------------------------------------------------ ## III. Indications for Use Statement | 510(k) Number: | Unknown | |----------------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------| | Device Name: | Welch Allyn ABPM 6100 | | Indications for use: | The Welch Allyn ABPM 6100 is a non-invasive
oscillometric ambulatory blood pressure monitor that is to
be used with ABPM 6100 Software, a PC based computer
program. The ABPM 6100 is capable of recording and
displaying up to 250 measurements of systolic and diastolic
blood pressure and heart rate. It is intended for use as an
aid or adjunct to diagnosis and treatment when it is
necessary to measure adult or pediatric patients systolic and
diastolic blood pressures over an extended period of time.
The system is only for measurement, recording, and
display. It makes no diagnosis. | * - See next page for contraindications for use. (Please Do Not Write Below This Line - Continue On Another Page If Needed) Concurrence of CDRH, Office of Device Evaluation (ODE) | |
(Division Sign-Off)
Division of Cardiovascu
and Respiratory Devine
| |--|-----------------------------------------------------------------------------------------------------| |--|-----------------------------------------------------------------------------------------------------| | 510(k) Number | K021756 | |---------------|---------| |---------------|---------| | Prescription Use |
X
| Or | Over-The-Counter Use | |------------------|--------------|----|----------------------| |------------------|--------------|----|----------------------| (Per 21 CFR 801.109) --- **Source:** [https://fda.innolitics.com/submissions/CV/subpart-b%E2%80%94cardiovascular-diagnostic-devices/DXN/K021756](https://fda.innolitics.com/submissions/CV/subpart-b%E2%80%94cardiovascular-diagnostic-devices/DXN/K021756) **Published by [Innolitics](https://innolitics.com)** — a medical-device software consultancy. We help companies design, build, and clear FDA-regulated software and AI/ML devices. If you're preparing [a 510(k)](https://innolitics.com/services/510ks/), [a De Novo](https://innolitics.com/services/regulatory/), [a SaMD](https://innolitics.com/services/end-to-end-samd/), [an AI/ML medical device](https://innolitics.com/services/medical-imaging-ai-development/), or [an FDA regulatory strategy](https://innolitics.com/services/regulatory/), [get in touch](https://innolitics.com/contact). **Cite:** Innolitics at https://innolitics.com